Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression

Oncogene volume 43, pages 2266–2278 (2024)Cite this article

Subjects

Abstract

Type 1 insulin-like growth factor receptor (IGF1R) plays an important role in cancer, however, posttranscriptional regulation such as N6-methyladenosine (m6A) of IGF1R remains unclear. Here, we reveal a role for a lncRNA Downregulated RNA in Cancer (DRAIC) suppress tumor growth and metastasis in clear cell Renal Carcinoma (ccRCC). Mechanistically, DRAIC physically interacts with heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) and enhances its protein stability by blocking E3 ligase F-box protein 11 (FBXO11)-mediated ubiquitination and proteasome-dependent degradation. Subsequently, hnRNPA2B1 destabilizes m6A modified-IGF1R, leading to inhibition of ccRCC progression. Moreover, four m6A modification sites are identified to be responsible for the mRNA degradation of IGF1R. Collectively, our findings reveal that DRAIC/hnRNPA2B1 axis regulates IGF1R mRNA stability in an m6A-dependent manner and highlights an important mechanism of IGF1R fate. These findings shed light on DRAIC/hnRNPA2B1/FBXO11/IGF1R axis as potential therapeutic targets in ccRCC and build a link of molecular fate between m6A-modified RNA and ubiquitin-modified protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: DRAIC represses tumor cell proliferation and metastasis.
Fig. 2: DRAIC directly binds with hnRNPA2B1.
Fig. 3: DRAIC blocks hnRNPA2B1 ubiquitination and degradation.
Fig. 4: IGF1R is negatively regulated by DRAIC and hnRNPA2B1.
Fig. 5: DRAIC and hnRNPA2B1 function through IGF1R in ccRCC.
Fig. 6: DRAIC and hnRNPA2B1 promote IGF1R mRNA degradation in an m6A-dependent manner.
Fig. 7: The identification of IGF1R m6A sites.

Similar content being viewed by others

Data availability

RNA-seq data of FPKM levels of LUSC, LUAD, ccRCC and ACC, were retrieved from TCGA. hnRNPA2B1 and IGF1R expression data and clinical data were downloaded from TCGA Pan-Cancer project. hnRNPA2B1 eCLIP-seq data (GSE86464) was obtained from the public database GEO; RNA-seq data of DRAIC and hnRNPA2B1 have been deposited in the GEO (GSE244891); M6A-seq data have been deposited in the GEO (GSE262500). The authors declare that the data supporting the findings of this study are available within the manuscript. No restriction on data availability applies. All other data supporting the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 2007;28:20–47.

    Article  CAS  PubMed  Google Scholar 

  2. Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM. The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 2008;14:6364–70.

    Article  CAS  PubMed  Google Scholar 

  3. Maki RG. Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol. 2010;28:4985–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Werner H, Karnieli E, Rauscher FJ, LeRoith D. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA. 1996;93:8318–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Titone R, Zhu M, Robertson DM. Mutual regulation between IGF-1R and IGFBP-3 in human corneal epithelial cells. J Cell Physiol. 2019;234:1426–41.

    Article  CAS  PubMed  Google Scholar 

  6. Jiang R, Wang M, Shen X, Huang S, Han J, Li L, et al. SUMO1 modification of IGF-1R combining with SNAI2 inhibited osteogenic differentiation of PDLSCs stimulated by high glucose. Stem Cell Res Ther 2021;12:543.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361:1346–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Pan Y, Gu Y, Liu T, Zhang Q, Yang F, Duan L, et al. Epitranscriptic regulation of HRAS by N(6)-methyladenosine drives tumor progression. Proc Natl Acad Sci USA. 2023;120:e2302291120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gu Y, Niu S, Wang Y, Duan L, Pan Y, Tong Z, et al. DMDRMR-Mediated Regulation of m(6)A-Modified CDK4 by m(6)A Reader IGF2BP3 Drives ccRCC Progression. Cancer Res. 2021;81:923–34.

    Article  CAS  PubMed  Google Scholar 

  10. Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016;534:575–8.

    Article  CAS  PubMed  Google Scholar 

  11. Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18–29.

    Article  CAS  PubMed  Google Scholar 

  13. Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, et al. N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161:1388–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Alarcón CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 Is a Mediator of m(6)A-dependent nuclear RNA processing events. Cell. 2015;162:1299–308.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Zhang Z, Lu YX, Liu F, Sang L, Shi C, Xie S, et al. lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1. Proc Natl Acad Sci USA. 2023;120:e2206694120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Yang X, Wen Y, Liu S, Duan L, Liu T, Tong Z, et al. LCDR regulates the integrity of lysosomal membrane by hnRNP K-stabilized LAPTM5 transcript and promotes cell survival. Proc Natl Acad Sci USA. 2022;119:e2110428119.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sakurai K, Reon BJ, Anaya J, Dutta A. The lncRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive nexus. Mol Cancer Res. 2015;13:828–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zeng Q, Saghafinia S, Chryplewicz A, Fournier N, Christe L, Xie YQ, et al. Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science. 2022;378:eabl7207.

    Article  CAS  PubMed  Google Scholar 

  20. Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18:206.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Huelga SC, Vu AQ, Arnold JD, Liang TY, Liu PP, Yan BY, et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 2012;1:167–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hofacker IL. Vienna RNA secondary structure server. Nucleic Acids Res. 2003;31:3429–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wu B, Su S, Patil DP, Liu H, Gan J, Jaffrey SR, et al. Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1. Nat Commun. 2018;9:420.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zhang H, Xia P, Yang Z, Liu J, Zhu Y, Huang Z, et al. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box(FBXO11)-mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma. Clin Transl Med. 2023;13:e1443.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Martinez FJ, Pratt GA, Van Nostrand EL, Batra R, Huelga SC, Kapeli K, et al. Protein-RNA networks regulated by normal and ALS-Associated Mutant HNRNPA2B1 in the nervous system. Neuron. 2016;92:780��95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Carboni JM, Wittman M, Yang Z, Lee F, Greer A, Hurlburt W, et al. BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR. Mol Cancer Ther. 2009;8:3341–9.

    Article  CAS  PubMed  Google Scholar 

  28. Wu Q, Tian AL, Kroemer G, Kepp O. Autophagy induction by IGF1R inhibition with picropodophyllin and linsitinib. Autophagy. 2021;17:2046–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gao S, Bajrami I, Verrill C, Kigozi A, Ouaret D, Aleksic T, et al. Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling. Cancer Res. 2014;74:5866–77.

    Article  CAS  PubMed  Google Scholar 

  30. Harper JE, Miceli SM, Roberts RJ, Manley JL. Sequence specificity of the human mRNA N6-adenosine methylase in vitro. Nucleic Acids Res. 1990;18:5735–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201–6.

    Article  CAS  PubMed  Google Scholar 

  32. Roberts JT, Porman AM, Johnson AM. Identification of m(6)A residues at single-nucleotide resolution using eCLIP and an accessible custom analysis pipeline. RNA (N. Y, NY). 2021;27:527–41.

    Article  CAS  Google Scholar 

  33. Hu L, Liu S, Peng Y, Ge R, Su R, Senevirathne C, et al. m(6)A RNA modifications are measured at single-base resolution across the mammalian transcriptome. Nat Biotechnol. 2022;40:1210–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ke S, Pandya-Jones A, Saito Y, Fak JJ, Vågbø CB, Geula S, et al. m(6)A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover. Genes Dev. 2017;31:990–1006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Li J, Chen Z, Chen F, Xie G, Ling Y, Peng Y, et al. Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein. Nucleic Acids Res. 2020;48:5684–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Xiao Y, Wang Y, Tang Q, Wei L, Zhang X, Jia G. An Elongation- and Ligation-Based qPCR Amplification Method for the Radiolabeling-Free Detection of Locus-Specific N(6) -Methyladenosine Modification. Angew Chem (Int ed Engl). 2018;57:15995–6000.

    Article  CAS  PubMed  Google Scholar 

  37. Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018;172:393–407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–41.

    Article  CAS  PubMed  Google Scholar 

  39. Zhu Y, Liu X, Wang Y, Pan Y, Han X, Peng B, et al. DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma. Cell Death Dis. 2022;13:456.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Tiessen I, Abildgaard MH, Lubas M, Gylling HM, Steinhauer C, Pietras EJ, et al. A high-throughput screen identifies the long non-coding RNA DRAIC as a regulator of autophagy. Oncogene. 2019;38:5127–41.

    Article  CAS  PubMed  Google Scholar 

  41. Sommer G, Heise T. Role of the RNA-binding protein La in cancer pathobiology. RNA Biol. 2021;18:218–36.

    Article  CAS  PubMed  Google Scholar 

  42. Chen T, Gu C, Xue C, Yang T, Zhong Y, Liu S, et al. LncRNA-uc002mbe.2 Interacting with hnRNPA2B1 Mediates AKT Deactivation and p21 Up-Regulation Induced by Trichostatin in Liver Cancer Cells. Front Pharm. 2017;8:669.

    Article  Google Scholar 

  43. Wang H, Liang L, Dong Q, Huan L, He J, Li B, et al. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma. Theranostics. 2018;8:2814–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Meng LD, Shi GD, Ge WL, Huang XM, Chen Q, Yuan H, et al. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway. Cancer Lett. 2020;494:107–20.

    Article  CAS  PubMed  Google Scholar 

  45. Arcaro A. Targeting the insulin-like growth factor-1 receptor in human cancer. Front Pharm. 2013;4:30.

    Article  Google Scholar 

  46. Riedemann J, Macaulay VM. IGF1R signalling and its inhibition. Endocr-Relat cancer. 2006;13:S33–43.

    Article  CAS  PubMed  Google Scholar 

  47. Werner H, Sarfstein R. Transcriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancer. Growth Horm IGF Res : Off J Growth Horm Res Soc Int IGF Res Soc. 2014;24:112–8.

    Article  CAS  Google Scholar 

  48. Shan YX, Yang TL, Mestril R, Wang PH. Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem. 2003;278:45492–8.

    Article  CAS  PubMed  Google Scholar 

  49. Zhang J, Huang FF, Wu DS, Li WJ, Zhan HE, Peng MY, et al. SUMOylation of insulin-like growth factor 1 receptor, promotes proliferation in acute myeloid leukemia. Cancer Lett. 2015;357:297–306.

    Article  CAS  PubMed  Google Scholar 

  50. Zheng Q, Gan H, Yang F, Yao Y, Hao F, Hong L, et al. Cytoplasmic m(1)A reader YTHDF3 inhibits trophoblast invasion by downregulation of m(1)A-methylated IGF1R. Cell Discov. 2020;6:12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Zhao Z, Qing Y, Dong L, Han L, Wu D, Li Y, et al. QKI shuttles internal m(7)G-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023;186:3208–3226.e27.

    Article  CAS  PubMed  Google Scholar 

  52. Pu X, Gu Z, Gu Z. ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer. J Cancer. 2020;11:5612–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Clough E, Barrett T. The Gene Expression Omnibus Database. Methods Mol Biol (Clifton, NJ). 2016;1418:93–110.

    Article  Google Scholar 

  54. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif). 2001;25:402–8.

    Article  CAS  PubMed  Google Scholar 

  55. Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, et al. Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. Cancer Cell. 2016;29:653–68.

    Article  CAS  PubMed  Google Scholar 

  56. Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014;15:1–21.

    Article  Google Scholar 

  58. Han X, Jiang S, Gu Y, Ding L, Zhao E, Cao D, et al. HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1. Cell Death Dis. 2023;14:327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (82203348, 82103230, 82025029 and 82150114); by grants from the National Key Research and Development Program of China (2022YFC3401001); by grants from the Fundamental Research Funds for the Central Universities; by grants from the Guizhou Science and Technology Department for Basic Research Project (QKHJC-2019-1192 and QKHJC-2020-1Y342); by grants from the Natural Science Basic Research Program of Shanxi Province (202303021222399).

Author information

Author notes

  1. These authors contributed equally: Ya Wen, Xiwang Yang.

Authors and Affiliations

  1. Medical College, Guizhou University, Guiyang, 550025, China

    Ya Wen & Xiaofeng Zhu

  2. Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Southeast University, Nanjing, 210096, China

    Ya Wen, Xiwang Yang, Yifei Li, Xueqing Zhao, Ao Ding, Shuwen Cheng, Xiaofeng Zhu, Bo Peng, Xiaoli Chang, Chang Zhang, Facai Yang, He Wang, Yibi Zhang & Shan Gao

  3. Shanxi Academy of Advanced Research and Innovation, Shanxi Provincial Key Laboratory of Protein Structure Determination, Taiyuan, 030032, China

    Ya Wen, Liqiang Duan, Tianyou Cheng & Tiantian Zhang

  4. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China

    Yifei Li, Ao Ding & Shizhong Zheng

  5. The People’s Hospital of Guizhou Province, Guiyang, 550002, China

    Dalong Song

  6. Medical School of Nanjing University, Nanjing, 210046, China

    Shuwen Cheng

  7. CAS Key Laboratory of Bio-medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, 215163, Suzhou, China

    Bo Peng & Yibi Zhang

  8. College of Veterinary Medicine, Shanxi Agricultural University, Shanxi, 030801, China

    Xiaoli Chang

  9. Department of Oncology, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510530, China

    Chang Zhang

  10. Department of Chemistry, College of Sciences, Shanghai University, Shanghai, 200444, China

    He Wang

  11. Department of Clinical Laboratory Diagnostics, Tianjin Medical University, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China

    Li Ren

Authors
  1. Ya Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiwang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yifei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xueqing Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ao Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dalong Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Liqiang Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shuwen Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiaofeng Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Bo Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiaoli Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Chang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Facai Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Tianyou Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. He Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Yibi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Tiantian Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Shizhong Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Li Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Shan Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Author contributions: SG, YW, and XWY. designed research, wrote the paper; YW, XWY, LFL, XQZ, AD, DLS, XFZ, BP, XLC, CZ, FCY, HW, YBZ, TTZ, SZZ and TYC performed research; LQD, SWC analyzed data; LR and SG reviewed the paper.

Corresponding authors

Correspondence to Li Ren or Shan Gao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wen, Y., Yang, X., Li, Y. et al. DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression. Oncogene 43, 2266–2278 (2024). https://doi.org/10.1038/s41388-024-03071-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41388-024-03071-8

Search

Advanced search

Quick links